global strategy lab

York U receives nearly $10 million from Wellcome to continue the fight against antimicrobial resistance

In a global health environment where funding is increasingly tight, York University based Global Strategy Lab (GSL) is launching a four-year strategic plan for its initiative, the AMR Policy Accelerator to drive progress against antimicrobial resistance (AMR). Unveiled today by GSL Director Mathieu JP Poirier and Accelerator Managing Director, Geneviève Boily-Larouche, the plan is supported by $9.6 million (£5 million) from Wellcome – a leading global health philanthropy.

Lack of gender lens in tobacco control research could stymie efforts to help smokers quit, York U researchers say

Ahead of World No Tobacco Day on May 31, York University researchers with Global Strategy Lab (GSL) have published a paper that finds a lack of gender analysis in tobacco control research. The researchers say this means that we could be missing out on important strategies accounting for gendered behaviors that could help smokers quit. The paper, published today in BMJ Tobacco Control, is the first in a series of papers coming out of York University and GSL on gender and smoking.

York U profs with Global Strategy Lab push ambitious 1–10–100 unifying goals on antimicrobial resistance ahead of crucial UN meeting

Researchers share goals of using a One Health-approach, to save 10 million lives and aim for 100 per cent sustainable access to effective antimicrobials in new policy paper TORONTO, September 18, 2024 – Antimicrobial resistance (AMR) contributes to millions of deaths annually, a problem that only becomes more pressing and will be a focus of […]

York profs to advance health research with more than $3.5M in federal CIHR funding

The Canadian Institutes of Health Research (CIHR) recently granted York University professors more than $3.5 million dollars combined, money that will go towards research that aims to help parents and neonatal infants, addresses equity and political barriers to global public health concerns and helps further our understanding the role of an important hormone in heart health. 

The war on antimicrobial "superbugs"...is it a losing battle?

War on bugs can’t be won, York U researchers declare

From a wartime spread of antimicrobial resistant disease in Ukraine, to superbugs in China causing “white lung” pneumonia in children, 2023 brought no shortage of new evidence that antimicrobial resistance (AMR) continues to be a pressing problem globally, and this pattern shows no sign of abating in 2024 unless a radical shift occurs.

Closing borders should be a last resort, York U pandemic study finds

New study finds most targeted COVID-19 border closures ineffective, likely illegal

A research team from the Global Strategy Lab (GSL) at York University looked at border closures implemented during the COVID-19 pandemic and concluded that many were ineffective, illegal and even when they did work, were so disruptive that in the future they should only be used when absolutely necessary.  

York University tackles urgent global health threat of antimicrobial resistance

New policy accelerator aims to bridge science and politics with $8.7 million backing from Wellcome Trust TORONTO, Nov. 22, 2022 – While recent health-care attention remains on the ‘triple threat’ of COVID-19, influenza and respiratory syncytial virus, we cannot overlook the emerging pandemic of antimicrobial resistance — an already critical problem with the potential to become so […]

York U expert: COP27 can help step up global environmental commitments

York U social epidemiologist says COP27 can help step up global environmental commitments. Among other topics, he is available to discuss what pandemic treaty negotiators can learn from international environmental law